Conformationally restricted biphenyl derivatives for use as hepatitis C virus inhibitors

Details for Australian Patent Application No. 2009215105 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Lavoie, Rico; Deon, Daniel H.; Ruediger, Edward H.; Meanwell, Nicholas A.; Goodrich, Jason; Good, Andrew C.; James, Clint A.; Bachand, Carol; Romine, Jeffrey Lee; Lopez, Omar D.; Nguyen, Van N.; St. Laurent, Denis R.; Martel, Alain; Belema, Makonen; Wang, Gan; Yang, Fukang; Snyder, Lawrence B.; Langley, David R.; Hamann, Lawrence G.

Agent A J Park

Pub. Number AU-A-2009215105

PCT Pub. Number WO2009/102568

Priority 61/028,266 13.02.08 US

Filing date 2 February 2009

Wipo publication date 20 August 2009

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4178 (2006.01)

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/102568 Priority application(s): WO2009/102568

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215106-Cell lines and methods for making and using them

2009215104-Bone implant composite